SE456995B - Foerfarande foer framstaellning av 5-metyl-3-(2-pyridyl)-2h, 5h-1,3-oxazino/5,6-c/-1,2-bensotiazin-2,4-(3h)-dion-6,6-dioxid - Google Patents

Foerfarande foer framstaellning av 5-metyl-3-(2-pyridyl)-2h, 5h-1,3-oxazino/5,6-c/-1,2-bensotiazin-2,4-(3h)-dion-6,6-dioxid

Info

Publication number
SE456995B
SE456995B SE8503109A SE8503109A SE456995B SE 456995 B SE456995 B SE 456995B SE 8503109 A SE8503109 A SE 8503109A SE 8503109 A SE8503109 A SE 8503109A SE 456995 B SE456995 B SE 456995B
Authority
SE
Sweden
Prior art keywords
acid
formula
compound
pyridyl
preparation
Prior art date
Application number
SE8503109A
Other languages
English (en)
Swedish (sv)
Other versions
SE8503109L (sv
SE8503109D0 (sv
Inventor
J G Lombardino
A Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE8503109D0 publication Critical patent/SE8503109D0/xx
Publication of SE8503109L publication Critical patent/SE8503109L/xx
Publication of SE456995B publication Critical patent/SE456995B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8503109A 1984-06-21 1985-06-20 Foerfarande foer framstaellning av 5-metyl-3-(2-pyridyl)-2h, 5h-1,3-oxazino/5,6-c/-1,2-bensotiazin-2,4-(3h)-dion-6,6-dioxid SE456995B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/623,251 US4656265A (en) 1984-06-21 1984-06-21 Cyclic prodrugs of antiinflammatory oxicams

Publications (3)

Publication Number Publication Date
SE8503109D0 SE8503109D0 (sv) 1985-06-20
SE8503109L SE8503109L (sv) 1985-12-22
SE456995B true SE456995B (sv) 1988-11-21

Family

ID=24497355

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503109A SE456995B (sv) 1984-06-21 1985-06-20 Foerfarande foer framstaellning av 5-metyl-3-(2-pyridyl)-2h, 5h-1,3-oxazino/5,6-c/-1,2-bensotiazin-2,4-(3h)-dion-6,6-dioxid

Country Status (29)

Country Link
US (1) US4656265A (fr)
JP (1) JPS6112692A (fr)
KR (1) KR870000627B1 (fr)
AT (1) AT393269B (fr)
AU (1) AU556117B2 (fr)
BE (1) BE902682A (fr)
CA (1) CA1234813A (fr)
CH (1) CH664157A5 (fr)
DE (1) DE3521722A1 (fr)
DK (1) DK171110B1 (fr)
EG (1) EG17534A (fr)
ES (1) ES8609333A1 (fr)
FI (1) FI852461L (fr)
FR (1) FR2566408B1 (fr)
GB (1) GB2160523B (fr)
GR (1) GR851489B (fr)
HU (1) HU196214B (fr)
IE (1) IE58135B1 (fr)
IL (1) IL75566A (fr)
IT (1) IT1190373B (fr)
LU (1) LU85961A1 (fr)
NL (1) NL193192C (fr)
NO (1) NO171727C (fr)
NZ (1) NZ212476A (fr)
PH (1) PH20816A (fr)
PL (1) PL146350B1 (fr)
PT (1) PT80664B (fr)
SE (1) SE456995B (fr)
ZA (1) ZA854649B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656265A (en) * 1984-06-21 1987-04-07 Pfizer Inc. Cyclic prodrugs of antiinflammatory oxicams
FR2597103B1 (fr) * 1986-04-15 1988-12-16 Provesan Sa Procede de preparation de derives d'oxazinobenzothiazine 6,6-dioxyde
WO1990011763A1 (fr) * 1989-04-06 1990-10-18 Pfizer Inc. N-ALCENYLBENZO[b]THIENO[3,2-b]OXAZINE-2,4-DIONES
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3492298A (en) * 1968-02-21 1970-01-27 Mcneilab Inc Oxazino-benzothiazine-6,6-dioxides
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3787324A (en) * 1971-03-01 1974-01-22 Warner Lambert Co 4-hydroxy-3-(3-isoxazolocarbamyl)-2h-1,2-benzothiazine 1,dioxides and process for their production
US3923801A (en) * 1974-09-23 1975-12-02 Mcneilab Inc Oxazinobenzothiazine 6,6-dioxides
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
US4309427A (en) * 1981-01-15 1982-01-05 Pfizer Inc. Benzothiazine dioxide derivatives
FR2528433A1 (fr) * 1982-06-15 1983-12-16 Provesan Sa Nouveaux derives d'oxazinobenzothiazine-6,6-dioxyde, leur preparation et leur application en tant que medicaments
US4656265A (en) * 1984-06-21 1987-04-07 Pfizer Inc. Cyclic prodrugs of antiinflammatory oxicams

Also Published As

Publication number Publication date
KR860000295A (ko) 1986-01-27
DK274185A (da) 1985-12-22
GB2160523B (en) 1988-06-22
DE3521722C2 (fr) 1988-09-15
GB2160523A (en) 1985-12-24
IT1190373B (it) 1988-02-16
DK274185D0 (da) 1985-06-18
GR851489B (fr) 1985-11-25
IE58135B1 (en) 1993-07-14
IL75566A (en) 1990-06-10
EG17534A (en) 1990-08-30
PT80664A (en) 1985-07-01
FR2566408B1 (fr) 1989-11-03
KR870000627B1 (ko) 1987-03-26
NL8501776A (nl) 1986-01-16
ES8609333A1 (es) 1986-07-16
BE902682A (fr) 1985-12-18
PL254117A1 (en) 1986-05-20
FI852461L (fi) 1985-12-22
NL193192C (nl) 1999-02-02
SE8503109L (sv) 1985-12-22
NZ212476A (en) 1988-08-30
FR2566408A1 (fr) 1985-12-27
US4656265A (en) 1987-04-07
IT8521218A0 (it) 1985-06-20
FI852461A0 (fi) 1985-06-20
CA1234813A (fr) 1988-04-05
ZA854649B (en) 1987-02-25
PT80664B (pt) 1988-01-22
LU85961A1 (fr) 1986-01-24
PL146350B1 (en) 1989-01-31
JPS6112692A (ja) 1986-01-21
HU196214B (en) 1988-10-28
ATA180785A (de) 1991-02-15
CH664157A5 (fr) 1988-02-15
HUT44564A (en) 1988-03-28
NO171727B (no) 1993-01-18
DK171110B1 (da) 1996-06-17
AU556117B2 (en) 1986-10-23
ES544397A0 (es) 1986-07-16
NO171727C (no) 1993-04-28
IE851521L (en) 1985-12-21
PH20816A (en) 1987-04-24
NL193192B (nl) 1998-10-01
NO852490L (no) 1985-12-23
SE8503109D0 (sv) 1985-06-20
AT393269B (de) 1991-09-25
JPH03874B2 (fr) 1991-01-09
AU4386485A (en) 1986-01-02
DE3521722A1 (de) 1985-12-19
GB8515437D0 (en) 1985-07-17

Similar Documents

Publication Publication Date Title
KR930006285B1 (ko) 티아졸 유도체의 제조방법
US4323567A (en) Arylmalonamido-1-oxadethiacephalosporins
BG60475B2 (bg) 4-хидрокси-2н-1,2-бензотиазин-3-карбоксамид-1,1-диоксиди, метод за получаването им и лекарствени средства,които ги съдържат
Perron et al. Derivatives of 6-aminopenicillanic acid. I. Partially synthetic penicillins prepared from α-aryloxyalkanoic acids
RU2263113C2 (ru) Производные 8,8а-дигидроиндено [1,2-d]тиазола, содержащие в положении 2 заместитель с сульфонамидной или сульфоновой структурой, способ их получения и их применение в качестве лекарственного средства
NO322309B1 (no) Indenotiazolforbindelser, legemiddel som inneholder slike forbindelser, fremgangsmate for deres fremstilling og deres anvendelse som anoreksimidler.
JPS609716B2 (ja) １，２―ベンズインチアゾリン―３―オン類、それらの製造法および医薬としての使用
PT1558580E (pt) N-sulfonil-4-metilenoamino-3-hidróxi-2-piridonas
SE444683B (sv) Syn-isomerer av 3-substituerade 7-amino-tiazolyl-acetamido-cefalosporansyraforeningar och farmaceutiska kompositioner till anvendning mot gram-positiva och gram-negativa bakterier
SE456995B (sv) Foerfarande foer framstaellning av 5-metyl-3-(2-pyridyl)-2h, 5h-1,3-oxazino/5,6-c/-1,2-bensotiazin-2,4-(3h)-dion-6,6-dioxid
EP0133887B1 (fr) Dérivés de rifampicine solubles dans l'eau
DK172034B1 (da) 4-OH-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt lægemidler med indhold deraf
GB2154585A (en) Prodrugs of antiinflammatory oxicams
US4451475A (en) Cyclic sulphenamide compounds, their production and their medicinal use
US4622322A (en) Aroyl substituted dihydro-1,4-thiazines
GB2149406A (en) Substituted ethane diimidamides
KR890005204B1 (ko) 벤조티아진 디옥사이드 유도체 및 이의 제조방법
FI95911C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-alkenyylibentso/b/tieno-/3,2-b/oksatsiini-2,4-dionien valmistamiseksi
US5217968A (en) N-alkylbenzo(b)thieno [3,2-b]oxazin-2,4-diones
HU190969B (en) Process for preparing aminoalkyl-imidazo-thidaiazolyl-alkane-carboxylic acid amides and pharmaceutical compositions thereof as active substances
KR870000907B1 (ko) 벤조티아진 디옥사이드 유도체의 제조방법
JPS63126884A (ja) オキサゾロチエノピリミジン誘導体
EP0005140A2 (fr) Dérivés de la 4-désoxy-thiazolo(5,4-c)rifamycine et procédé pour leur préparation
WO2011083265A1 (fr) Nouveaux derives de benzothiadiazines cyclopropylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8503109-4

Format of ref document f/p: F

NUG Patent has lapsed
NUG Patent has lapsed